LGG probiotic may protect day care kids from respiratory illness: Study

By Stephen Daniells

- Last updated on GMT

Related tags: Probiotic

LGG probiotic may protect day care kids from respiratory illness: Study
Long term consumption of milk containing the probiotic Lactobacillus rhamnosus GG strain may protect children in day care from respiratory illness, says a new study from Finland.

Led by researchers from Valio, Finnish scientists report that, despite benefits for kids in day care, no such benefits were observed in the general population. The study was funded by Valio Ltd.

Twenty-eight weeks of supplementation were associated with only 4.7 days per month with respiratory illness, compared to 5.7 days per month in the placebo group, according to findings published in the European Journal of Clinical Nutrition​.

According to UNICEF, a global average of 16% of children under five suffer from acute respiratory infections.

The efficacy of probiotics in the prevention of infections in children who attend day care centers has been investigated in several studies, and these have yielded contradictory results. A study from Croatia published in 2009 that found that LGG may decrease the risk of upper respiratory tract infections including rhinitis, pharyngitis, sinusitis, otitis, and the common cold in children attending day care (Clinical Nutrition​, Vol. 29, pp. 312-316).

Care needed

“Long-term consumption of ​L. rhamnosus GG reduced the occurrence of respiratory illness in children attending day care centers only in the completed cases subgroup analysis based on recovery of GG in fecal samples,”​ wrote the researchers.

Commenting on the contradictory results in the literature, the researchers said that future studies are needed to further evaluate the links, but that careful screening of the subjects is required before starting the study.

In addition, they recommended careful selection of study country. “Wide availability of GG in a range of products can make the avoidance of GG containing products very challenging for the subjects.

“Dose–response setting to identify the required dose of GG for respiratory symptom reduction in children is also warranted.”

Study details

The researchers recruited 523 children aged between 2 and 6 to participate in their 28 week study. The children received either normal milk or the same milk with LGG. According to their analysis, the LGG content of fresh milk was between 0.67 million and 1.9 million colony forming units per milliliter of milk (cfu/ml), while the content in the end-of-shelf life product was between 0.2 million and 1.2 million cfu/ml.

While data from the general population did not show any differences between the placebo and LGG groups for the number of days with respiratory symptoms, the researchers did record observe a reduction of 1 day of symptoms in the LGG group using data from children that showed the presence of LGG in feces.

“Future clinical trials are warranted to clarify the association between fecal recovery of a probiotic and the symptom prevalence.”

Source: European Journal of Clinical Nutrition
Published online ahead of print, doi:10.1038/ejcn.2012.62
“Milk containing probiotic Lactobacillus rhamnosus GG and respiratory illness in children: a randomized, double-blind, placebo-controlled trial”
Authors: M. Kumpu, R.A. Kekkonen, H. Kautiainen, S. Jarvenpaa, A. Kristo, P. Huovinen, A. Pitkaranta, R. Korpela, K. Hatakka

Related news

Show more

Related products

show more

A microbiome solution for every application.

A microbiome solution for every application.

ADM | 07-Dec-2021 | Infographic

Gut health and its impact on overall wellbeing are key drivers for today’s health-conscious consumers. ADM’s microbiome solutions are designed to help...

Expand into new probiotic possibilities

Expand into new probiotic possibilities

Probi AB | 09-Nov-2021 | Application Note

Expand your product range with innovative probiotic solutions in new health areas. Probi ClinBac™, an exclusive range of patented probiotic health concepts,...

OPUNXIA ORGANIC FOR PEOPLE AND PLANET WELLNESS

OPUNXIA ORGANIC FOR PEOPLE AND PLANET WELLNESS

BIONAP Srl | 28-Oct-2021 | Data Sheet

OPUNXIA™ has a high concentrated and standardized polysaccharides profile. It is produced in powder form through specialized technologies to ensure the...

Related suppliers

Follow us

Products

View more

Webinars